Researcher
Jurgen Joossens
- Keywords:Pharmacy and pharmacology
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal chemistry, Medicinal products, Pharmaceutical analysis and quality assurance, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Other medical and health sciences
Affiliations
- Tech Transfer Office (TTO) (Research group)
Responsible
From1 Nov 2016 → Today - Medicinal Chemistry (UAMC) (Research group)
Member
From1 Oct 2005 → 31 Oct 2016
Projects
1 - 10 of 22
- SkillsApp, market exploration and validation of innovative web application to objectify skills evaluation.From1 May 2024 → TodayFunding: IOF - technology validation in lab
- AI-driven optimalisation of the user experience (UX) of digital tools.From1 Sep 2023 → TodayFunding: IOF - technology concept exploration
- CremAN: Simulating Input/Output and CAN communication for testing remanufactured automotive parts.From1 May 2023 → TodayFunding: IOF - technology concept exploration
- Optimization of the cryopreservation procedure of cells for therapeutic and research applications using Design of Experiments.From1 Jan 2023 → 31 Dec 2023Funding: IOF - technology concept exploration
- IOF Alliance Valorisation Manager UAntwerpen - UZAFrom7 Nov 2022 → TodayFunding: IOF - mandates
- IOF Valorisation Life SciencesFrom7 Mar 2022 → TodayFunding: IOF - mandates
- Development of a cascading approach for zero-waste valorization of agricultural and food residues.From1 Dec 2021 → 30 Nov 2023Funding: IOF - technology concept exploration
- IOF Valorisation - Project DevelopmentFrom1 Jul 2021 → TodayFunding: IOF - mandates
- Towards integrated Practices of Schools, Reception Centres and Leisure Time Facilities for Refugee Children: an Action Research.From1 May 2021 → 30 Apr 2023Funding: IOF - technology concept exploration
- IOF Valorisation of social and human sciences.From1 Mar 2021 → TodayFunding: IOF - mandates
Publications
41 - 50 of 50
- Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission(2013)
Authors: Kevin Ariën, Muthusamy Venkatraj, Johan Michiels, Jurgen Joossens, Katleen Vereecken, Pieter Van Der Veken, Saïd Abdellati, Vicky Cuylaerts, Tania Crucitti, Leo Heyndrickx, et al.
Pages: 2038 - 2047 - Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)(2012)
Authors: Muthusamy Venkatraj, Jonas Messagie, Jurgen Joossens, Achiel Haemers, Pieter Van Der Veken, Koen Augustyns
Pages: 1557 - 1568 - Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity(2012)
Authors: Oksana Ryabtsova, Koen Jansen, Sebastiaan Van Goethem, Jurgen Joossens, Jonathan D. Cheng, Ingrid De Meester, Koen Augustyns, Pieter Van Der Veken
Pages: 3412 - 3417 - Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents(2012)
Authors: Muthusamy Venkatraj, Kevin Ariën, Jan Heeres, Jurgen Joossens, Jonas Messagie, Johan Michiels, Pieter Van Der Veken, Guido Vanham, Koen Augustyns
Pages: 7174 - 7178 - Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs)(2011)
Authors: Muthusamy Venkatraj, Jan Heeres, Bertrand Dirié, Jurgen Joossens, Sebastiaan van Goethem, Pieter Van Der Veken, Johan Michiels, Koen Augustyns
Pages: 5924 - 5934 - Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9)(2011)
Authors: Sebastiaan van Goethem, Veerle Matheeussen, Jurgen Joossens, Xin Chen, Ingrid De Meester, Achiel Haemers, Koen Augustyns, Pieter Van Der Veken
Pages: 5737 - 5746 - $\_alpha$-ketoheterocycles as inhibitors of **Leishmania mexicana** cysteine protease CPB(2010)
Authors: Koen Steert, Maya Berg, Jeremy C. Mottram, Gareth D. Westrop, Graham H. Coombs, Paul Cos, Jurgen Joossens, Pieter Van Der Veken, Achiel Haemers, Koen Augustyns
Pages: 1734 - 1748 - Evaluation of nucleoside hydrolase inhibitors for the treatment of African trypanosomiasis(2010)
Authors: Maya Berg, Pieter Van Der Veken, Jurgen Joossens, Mohammed I. -al Salabi, Valeria Castagna, Francesca Giannese, Paul Cos, Wim Versées, Jan Steyaert, Philippe Grellier, et al.
Pages: 1900 - 1908 - Design and evaluation of **Trypanosoma brucei** metacaspase inhibitors(2010)
Authors: Maya Berg, Pieter Van Der Veken, Jurgen Joossens, Venkatraj Muthusamy, Matthias Breugelmans, Catherine X. Moss, Jana Rudolf, Paul Cos, Graham H. Coombs, Achiel Haemers, et al.
Pages: 2001 - 2006 - Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives(2009)
Authors: Ibrahim el Sayed, Pieter Van Der Veken, Koen Steert, Liene Dhooghe, Steven Hostyn, Gitte Van Baelen, Guy Lemiere, Bert Maes, Paul Cos, Jurgen Joossens, et al.
Pages: 2979 - 2988
Patents
1 - 10 of 10
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- Halogenated benzotropolones as ATG4B inhibitors (Inventor)
- Halogenated benzotropolones as atg4b inhibitors (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- KLK4 inhibitors (Inventor)
- Halogenated benzotropolones as atg4b inhibitors (Inventor)
- Triazines with suitable spacers for treatment and/or prevention of HIV infections (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)